Clinical Trial Update: The Use of Low Molecular Weight Heparin in Traumatic Brain Injury [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update reporting the completion of a study evaluating low molecular weight heparin in traumatic brain injury, with venous thrombosis list…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury
• Venous Thrombosis

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: Hennepin Healthcare Research Institute | Conditions: Brain Injury, Venous Thrombosis | Phase 4 | Status: COMPLETED